NCT01419704View on ClinicalTrials.gov

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2011

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemiaDiamond-Blackfan AnemiaBone Marrow Failure SyndromesAlpha-ThalassemiaBeta-Thalassemia
Interventions
BIOLOGICAL

Enriched Hematopoetic Stem Cell Infusion

Enriched Hematopoetic Stem Cell Infusion

Trial Locations (3)

27705

Duke University Medical Center, Durham

40202

University of Louisville, Louisville

60611

Northwestern Memorial Hospital, Chicago

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
lead

Talaris Therapeutics Inc.

INDUSTRY

collaborator

Duke University

OTHER

NCT01419704 - Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies | Biotech Hunter | Biotech Hunter